File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.coi.2005.05.009
- Scopus: eid_2-s2.0-20544456584
- PMID: 15950449
- WOS: WOS:000230673900011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Pathogenesis of severe acute respiratory syndrome
Title | Pathogenesis of severe acute respiratory syndrome |
---|---|
Authors | |
Issue Date | 2005 |
Publisher | Elsevier Ltd, Current Opinion Journals. The Journal's web site is located at http://www.elsevier.com/locate/coi |
Citation | Current Opinion In Immunology, 2005, v. 17 n. 4 SPEC. ISS., p. 404-410 How to Cite? |
Abstract | Severe acute respiratory syndrome (SARS) is a zoonotic infectious disease caused by a novel coronavirus (CoV). The tissue tropism of SARS-CoV includes not only the lung, but also the gastrointestinal tract, kidney and liver. Angiotensin-converting enzyme 2 (ACE2), the C-type lectin CD209L (also known L-SIGN), and DC-SIGN bind SARS-CoV, but ACE2 appears to be the key functional receptor for the virus. There is a prominent innate immune response to SARS-CoV infection, including acute-phase proteins, chemokines, inflammatory cytokines and C-type lectins such as mannose-binding lectin, which plays a protective role against SARS. By contrast there may be a lack of type 1 interferon response. Moreover, lymphopenia with decreased numbers of CD4+ and CD8 + T cells is common during the acute phase. Convalescent patients have IgG-class neutralizing antibodies that recognize amino acids 441-700 of the spike protein (S protein) as the major epitope. © 2005 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/79236 |
ISSN | 2023 Impact Factor: 6.6 2023 SCImago Journal Rankings: 2.841 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yu, LL | en_HK |
dc.contributor.author | Malik Peiris, JS | en_HK |
dc.date.accessioned | 2010-09-06T07:52:14Z | - |
dc.date.available | 2010-09-06T07:52:14Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | Current Opinion In Immunology, 2005, v. 17 n. 4 SPEC. ISS., p. 404-410 | en_HK |
dc.identifier.issn | 0952-7915 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/79236 | - |
dc.description.abstract | Severe acute respiratory syndrome (SARS) is a zoonotic infectious disease caused by a novel coronavirus (CoV). The tissue tropism of SARS-CoV includes not only the lung, but also the gastrointestinal tract, kidney and liver. Angiotensin-converting enzyme 2 (ACE2), the C-type lectin CD209L (also known L-SIGN), and DC-SIGN bind SARS-CoV, but ACE2 appears to be the key functional receptor for the virus. There is a prominent innate immune response to SARS-CoV infection, including acute-phase proteins, chemokines, inflammatory cytokines and C-type lectins such as mannose-binding lectin, which plays a protective role against SARS. By contrast there may be a lack of type 1 interferon response. Moreover, lymphopenia with decreased numbers of CD4+ and CD8 + T cells is common during the acute phase. Convalescent patients have IgG-class neutralizing antibodies that recognize amino acids 441-700 of the spike protein (S protein) as the major epitope. © 2005 Elsevier Ltd. All rights reserved. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Elsevier Ltd, Current Opinion Journals. The Journal's web site is located at http://www.elsevier.com/locate/coi | en_HK |
dc.relation.ispartof | Current Opinion in Immunology | en_HK |
dc.title | Pathogenesis of severe acute respiratory syndrome | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0952-7915&volume=17&issue=4&spage=404&epage=410&date=2005&atitle=Pathogenesis+of+severe+acute+respiratory+syndrome | en_HK |
dc.identifier.email | Malik Peiris, JS: malik@hkucc.hku.hk | en_HK |
dc.identifier.authority | Malik Peiris, JS=rp00410 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.coi.2005.05.009 | en_HK |
dc.identifier.pmid | 15950449 | - |
dc.identifier.scopus | eid_2-s2.0-20544456584 | en_HK |
dc.identifier.hkuros | 102018 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-20544456584&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 17 | en_HK |
dc.identifier.issue | 4 SPEC. ISS. | en_HK |
dc.identifier.spage | 404 | en_HK |
dc.identifier.epage | 410 | en_HK |
dc.identifier.isi | WOS:000230673900011 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Yu, LL=8617704200 | en_HK |
dc.identifier.scopusauthorid | Malik Peiris, JS=7005486823 | en_HK |
dc.identifier.issnl | 0952-7915 | - |